Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid
Alberto Lleó(Hospital de Sant Pau), Olivia Belbin(Hospital de Sant Pau)
Cited by 252
Related Papers
A multicentre validation study of the diagnostic value of plasma neurofilament light
|Nature Communications|2021|554
CSF biomarker variability in the Alzheimer's Association quality control program
|Alzheimer s & Dementia|2013|386
APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease
|Nature Medicine|2024|333
Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics
|Brain|2020|221
Inflammatory biomarkers in Alzheimer's disease plasma
|Alzheimer s & Dementia|2019|207